Gregory L Weaver's Net Worth

$282 Thousand

Estimate Recalculated May 14, 2024 03:27PM EST

Who is Gregory L Weaver?

Gregory L Weaver does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include NASTECH PHARMACEUTICAL CO INC, Fibrocell Science, Inc., ATAI Life Sciences N.V., CELSION CORP, Egalet Corp, PONIARD PHARMACEUTICALS, INC., ATOSSA THERAPEUTICS, INC., Eloxx Pharmaceuticals, Inc., SCOLR Pharma, Inc., and SIRNA THERAPEUTICS INC.

SEC CIK

Gregory L Weaver's CIK is 0001251779

Past Insider Trading and Trends

2009 was Gregory L Weaver's most active year for acquiring shares with 9 total transactions. Gregory L Weaver's most active month to acquire stocks was the month of April. 2019 was Gregory L Weaver's most active year for disposing of shares, totalling 7 transactions. Gregory L Weaver's most active month to dispose stocks was the month of December. 2009 saw Gregory L Weaver paying a total of $570,321.75 for 230,000 shares, this is the most they've acquired in one year. In 2021 Gregory L Weaver cashed out on 329,162 shares for a total of $965,170.86, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

NASTECH PHARMACEUTICAL CO INC (ATRX) Snapshot price: $0.0164

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+88.24%
7.5K
—
—
16K
May 25
Form 4/A
+750.00%
7.5K
—
—
8.5K
Jun 9
Form 4
+750.00%
7.5K
—
—
8.5K
Jun 9
Form 4
—
0
—
—
0
Sep 10
Form 4/A
—
0
—
—
0
Form 4
—
0
—
—
0
No matching records found

Fibrocell Science, Inc. No price found

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 17
Form 4
∞
10K
$3.51
$35,080.00
10K
Nov 20
Form 4
—
0
—
—
0
Aug 26
Form 3
—
0
—
—
0
No matching records found

ATAI Life Sciences N.V. (ATAI) Snapshot price: $1.8

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 2
Form 4
∞
4.67K
$15.00
$69,990.00
4.67K
Jun 22
Form 4
—
0
—
—
0
Jun 17
Form 3
—
0
—
—
0
No matching records found

CELSION CORP (IMNN) Snapshot price: $0.5495

CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-37.27K
$1.06
-$39,508.32
0
Mar 19
Form 4
+30.16%
8.64K
$2.77
$23,921.72
37.27K
Dec 18
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Feb 27
Form 4
+21.15%
5K
$2.15
$10,750.00
28.64K
Dec 6
Form 4
—
0
—
—
0
Jul 8
Form 4
+57.57%
8.64K
$2.77
$23,921.72
23.64K
May 26
Form 4
—
0
—
—
0
Feb 25
Form 4
+50.00%
5K
$3.10
$15,500.00
15K
Sep 16
Form 4
—
0
—
—
0
Feb 19
Form 4
—
0
—
—
0
Jan 19
Form 4
—
0
—
—
0
Mar 15
Form 4
—
0
—
—
0
Mar 22
Form 4
∞
10K
$3.50
$35,000.00
10K
Feb 23
Form 4
—
0
—
—
0
Mar 15
Form 4
—
0
—
—
0
Aug 12
Form 3
—
0
—
—
0
No matching records found

Egalet Corp No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 31
Form 4
—
0
—
—
0
May 14
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Feb 5
Form 3
—
0
—
—
0
No matching records found